Mapp Biopharmaceutical

The US National Institutes of Health-led ACTIV clinical trial program is using master protocols to quickly assess the efficacy of potential COVID-19 therapeutics. One need look no further than the Foo

The first clinical trial in the US to test an experimental COVID-19 treatment highlights the central role that master protocol trials can play in coordinating R&D in the face of an emerging threat. Na

George Scangos made a surprising shift when the former Biogen CEO left the world of big biotech to lead an infectious disease-focused start-up. Vir Biotechnology Inc. emerged in early 2017 with $1

The US Food and Drug Administration got right back into the novel drug approval game after a week off, giving its go-ahead to Ardelyx Inc. 's Ibsrela (tenapanor) for the treatment of irritable bowel